2010 | Livio Trusolino, Andrea Bertotti & Paolo M. Comoglio
This is the author's manuscript. The article discusses MET signaling, its roles in development, organ regeneration, and cancer. MET is a tyrosine kinase receptor that promotes tissue remodeling through growth, survival, and migration cues. MET signaling is regulated by qualitative and quantitative mechanisms, including signal transducers, subcellular compartmentalization, and interactions with adaptor proteins or degradation of its extracellular domain. MET signaling can be harnessed for regenerative medicine, while inhibition may slow tumor progression. MET signaling is crucial for embryonic development, tissue repair, and cancer metastasis. It is involved in cell motility, survival, and proliferation, and is regulated by various signaling pathways, including MAPK, PI3K-Akt, STAT, and NF-κB. MET signaling is also involved in organ regeneration, particularly in the liver and kidney, and in cancer progression, where it promotes tumor growth and metastasis. MET signaling is regulated by various mechanisms, including internalization, endosomal degradation, and regulated proteolysis. The article also discusses the role of MET in wound healing and the potential therapeutic implications of targeting MET signaling in cancer.This is the author's manuscript. The article discusses MET signaling, its roles in development, organ regeneration, and cancer. MET is a tyrosine kinase receptor that promotes tissue remodeling through growth, survival, and migration cues. MET signaling is regulated by qualitative and quantitative mechanisms, including signal transducers, subcellular compartmentalization, and interactions with adaptor proteins or degradation of its extracellular domain. MET signaling can be harnessed for regenerative medicine, while inhibition may slow tumor progression. MET signaling is crucial for embryonic development, tissue repair, and cancer metastasis. It is involved in cell motility, survival, and proliferation, and is regulated by various signaling pathways, including MAPK, PI3K-Akt, STAT, and NF-κB. MET signaling is also involved in organ regeneration, particularly in the liver and kidney, and in cancer progression, where it promotes tumor growth and metastasis. MET signaling is regulated by various mechanisms, including internalization, endosomal degradation, and regulated proteolysis. The article also discusses the role of MET in wound healing and the potential therapeutic implications of targeting MET signaling in cancer.